Real-time Euronext Paris 10:24:06 2024-04-24 am EDT 5-day change 1st Jan Change
13 EUR -1.14% Intraday chart for LUMIBIRD -6.47% +6.73%
Sales 2024 * 224M 240M Sales 2025 * 245M 262M Capitalization 290M 310M
Net income 2024 * 15M 16.03M Net income 2025 * 19M 20.3M EV / Sales 2024 * 1.61 x
Net Debt 2024 * 71.35M 76.23M Net Debt 2025 * 54.95M 58.71M EV / Sales 2025 * 1.41 x
P/E ratio 2024 *
19.6 x
P/E ratio 2025 *
15 x
Employees 989
Yield 2024 *
-
Yield 2025 *
-
Free-Float 40.23%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.76%
1 week-6.12%
Current month-0.53%
1 month-3.05%
3 months+20.61%
6 months-2.76%
Current year+7.14%
More quotes
1 week
13.05
Extreme 13.05
14.40
1 month
12.80
Extreme 12.8
14.50
Current year
10.40
Extreme 10.4
15.48
1 year
10.40
Extreme 10.4
16.44
3 years
10.40
Extreme 10.4
24.35
5 years
5.40
Extreme 5.4
24.35
10 years
5.40
Extreme 5.4
24.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 16-11-17
Director of Finance/CFO - 22-11-30
Director of Finance/CFO - 18-09-30
Members of the board TitleAgeSince
Chief Executive Officer 61 16-11-17
Director/Board Member - 16-04-04
Director/Board Member - 16-11-17
More insiders
Date Price Change Volume
24-04-24 13 -1.14% 10 670
24-04-23 13.15 -6.07% 24,164
24-04-22 14 0.00% 4,665
24-04-19 14 +0.36% 784
24-04-18 13.95 +0.36% 1,760

Real-time Euronext Paris, April 24, 2024 at 05:20 am EDT

More quotes
LUMIBIRD figure parmi les plus grands spécialistes mondiaux du laser. Fort de 50 années d'expérience et maîtrisant les technologies de laser à solides, de diodes laser et de laser à fibres, LUMIBIRD conçoit, fabrique et distribue des lasers haute performance à usages scientifiques (laboratoires de recherche et universités), industriels (production, défense/spatial, capteurs Lidar) et médical (ophtalmologie).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
13.15 EUR
Average target price
17.85 EUR
Spread / Average Target
+35.74%
Consensus

Quarterly revenue - Rate of surprise